Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash & Current Investments: 2016-2025

Historic Cash & Current Investments for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $285.9 million.

  • Collegium Pharmaceutical's Cash & Current Investments rose 138.30% to $285.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $868.6 million, marking a year-over-year decrease of 14.86%. This contributed to the annual value of $162.8 million for FY2024, which is 47.59% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Cash & Current Investments stood at $285.9 million for Q3 2025, which was up 28.68% from $222.2 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Cash & Current Investments registered a high of $325.5 million during Q2 2023, and its lowest value of $106.7 million during Q1 2022.
  • Over the past 3 years, Collegium Pharmaceutical's median Cash & Current Investments value was $271.6 million (recorded in 2024), while the average stood at $253.5 million.
  • In the last 5 years, Collegium Pharmaceutical's Cash & Current Investments soared by 165.21% in 2023 and then crashed by 60.61% in 2024.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Cash & Current Investments stood at $186.4 million in 2021, then decreased by 6.83% to $173.7 million in 2022, then soared by 78.80% to $310.5 million in 2023, then crashed by 47.59% to $162.8 million in 2024, then spiked by 138.30% to $285.9 million in 2025.
  • Its Cash & Current Investments stands at $285.9 million for Q3 2025, versus $222.2 million for Q2 2025 and $197.8 million for Q1 2025.